Net Cash Provided by (Used in) Operating Activities |
-252 K |
USD |
+17.8% |
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
2.07 M |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
-2.03 M |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
112 K |
USD |
-84.6% |
Mar 31, 2023 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
527 K |
USD |
+308% |
Dec 31, 2022 |
Q4 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2022 |
2022 |
Deferred Tax Assets, Gross |
527 K |
USD |
+308% |
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2023 |
Q1 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-298 K |
USD |
-228% |
Dec 31, 2022 |
2022 |
Current Income Tax Expense (Benefit) |
620 K |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Preferred Stock, Shares Authorized |
1 M |
shares |
0% |
Mar 31, 2023 |
Q1 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Additional Paid in Capital |
0 |
USD |
-100% |
Sep 30, 2022 |
Q3 2022 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2023 |
Q1 2023 |
Current State and Local Tax Expense (Benefit) |
239 K |
USD |
|
Dec 31, 2022 |
2022 |
Current Federal Tax Expense (Benefit) |
519 K |
USD |
|
Dec 31, 2022 |
2022 |
Deferred Tax Assets, Net of Valuation Allowance |
667 K |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Deferred State and Local Income Tax Expense (Benefit) |
-128 K |
USD |
-236% |
Dec 31, 2022 |
2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2023 |
Q1 2023 |